Swissmedic approval to produce medical cannabis products
Canexis Pharma AG (“Canexis”), an up-and-coming Swiss company in the field of pharmaceutical cannabis products, has received the manufacturing and narcotics license for cannabis medicines from Swissmedic. These licenses are a significant milestone for Canexis, as they enable the company to produce high-quality CBD and THC-based active pharmaceutical ingredients for the Swiss and international markets. After four years of intensive […]